Related Experiment Videos
[Serum neuron-specific enolase in small cell bronchial cancers]
B Milleron1, J Cadranel, S Dominique
1Centre de Pneumologie, Hôpital Tenon, Paris.
Revue De Pneumologie Clinique
|January 1, 1990
Summary
Serum neuron-specific enolase (SNE) shows good specificity but cannot diagnose small cell carcinoma alone. However, SNE levels correlate with tumor extent and chemotherapy response, offering prognostic value.
Area of Science:
- Biochemistry
- Oncology
- Clinical Diagnostics
Context:
- Small cell carcinoma diagnosis and treatment monitoring.
- Role of serum biomarkers in cancer management.
- Limitations of current diagnostic tools.
Purpose:
- To evaluate the utility of serum neuron-specific enolase (SNE) as a diagnostic and prognostic marker for small cell carcinoma.
- To explore the correlation between SNE levels, tumor burden, and response to chemotherapy.
Summary:
- Serum neuron-specific enolase (SNE) exhibits high specificity but is insufficient for diagnosing small cell carcinoma.
- SNE levels demonstrate a dual correlation with tumoral extension and the clinical response to chemotherapy.
- Repeated SNE assays are valuable for assessing treatment response (normalization) and predicting disease progression (elevation), indicating prognostic significance.
Impact:
- Highlights the prognostic value of SNE in managing small cell carcinoma.
- Suggests repeated SNE monitoring can aid in treatment decisions and early detection of relapse.
- Emphasizes the need for combined diagnostic approaches beyond SNE for definitive diagnosis.